Evidence map›Paper›PMID 24444660›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2014

Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.

Rahul Suresh, Martha Grogan, Joseph J Maleszewski, Patricia A Pellikka, Mazen Hanna, Angela Dispenzieri, Naveen L Pereira

Abstract readComparative Study
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Epigenomic Profiles of African-AmericanCirculation. Genomic and precision medicine · 2021
    Article
  9. Review
  10. Observational
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rahul SureshMayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota.
Martha GroganDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Joseph J MaleszewskiDivision of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.
Patricia A PellikkaDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Mazen HannaDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
Angela DispenzieriDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Naveen L PereiraDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: pereira.naveen@mayo.edu.
Mayo Clinic · USCleveland Clinic · US

Funding

MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135NCRR NIH HHS 1 UL1 RR024150-01NCRR NIH HHS UL1 RR024150
6 · The paper itself

Abstract

backgroundIncreased interventricular septal (IVS) thickness on echocardiography is a diagnostic criterion for cardiac amyloidosis and classically precedes decrement in left ventricular ejection fraction (LVEF). The investigators describe patients with histologically confirmed cardiac amyloidosis who had significant myocardial dysfunction (LVEF ≤ 40%) despite having normal IVS thickness.

methodsAll patients with systemic amyloidosis and LVEFs ≤ 40% were analyzed to identify the prevalence of normal IVS thickness. Patients with known histories of cardiomyopathy or coronary artery disease were excluded. Histologic evaluation of tissue included assessment of amyloid burden and average myocyte diameter.

resultsThere were 255 patients with amyloidosis with LVEFs ≤ 40%, of whom seven (3%) had normal IVS thickness and histologic confirmation of cardiac involvement. Of these, six had immunoglobulin light chain amyloidosis, and one had senile amyloidosis. A majority of patients (86%) presented with new-onset cardiac dysfunction associated with edema and/or dyspnea. Electrocardiographic findings included low voltage (43%) and a pseudoinfarct pattern (29%). The 1-year survival from initial tissue diagnosis in the cohort with normal IVS thickness was similar to matched patients with amyloidosis with increased IVS thickness and LVEF ≤ 40% (21% vs 18%, respectively, P = .32). Myocardial tissue amyloid burden and average myocyte diameter were significantly reduced in cases compared with controls.

conclusionsCardiac amyloidosis can uncommonly present with normal IVS thickness despite significant myocardial dysfunction. The prognosis of these patients is as poor as those with increased IVS thickness. Amyloidosis should be considered in the differential diagnosis of patients with cardiomyopathy and reduced LVEFs despite normal IVS thickness.

Indexed as

AgedAmyloidosisCardiomyopathiesEchocardiographyFemaleHeart Septal Defects, VentricularHeart SeptumHumansImage Interpretation, Computer-AssistedMaleMiddle AgedOrgan SizeReproducibility of ResultsRetrospective StudiesSensitivity and SpecificityAmyloidCardiomyopathyDiagnosisEchocardiographyHeart failure

Identifiers

PMID24444660
PMCPMC3972307
OpenAlexW2060754625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.